Molecular targets underlying the anticancer effects of quercetin: An update

Nutrients

Volumn 8, Issue 9, 2016, Pages

  Khan, Fazlullah ^a,b   Niaz, Kamal ^a,b   Maqbool, Faheem ^a,b   Hassan, Fatima Ismail ^a,b   Abdollahi, Mohammad ^a,b   Nagulapalli Venkata, Kalyan C ^c   Nabavi, Seyed Mohammad ^d   Bishayee, Anupam ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Larkin Health Science Institute   (United States)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioavailability; Cancer prevention; Diet; DNA damage; Polyphenols; Quercetin

Indexed keywords

AGLYCONE; FLAVONOID; GLUTATHIONE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; POLYPHENOL; QUERCETIN; QUERCITRIN; RUTOSIDE; STAT PROTEIN; SUPEROXIDE DISMUTASE; TELOMERASE INHIBITOR; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; ANTINEOPLASTIC AGENT;

AGING; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOAVAILABILITY; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; DNA DAMAGE; DOWN REGULATION; DRUG MECHANISM; LIPID PEROXIDATION; METABOLISM; MOLECULARLY TARGETED THERAPY; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; FRUIT; GENETICS; HEALTHY DIET; HUMAN; NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; VEGETABLE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; FRUIT; HEALTHY DIET; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; OXIDATIVE STRESS; QUERCETIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; VEGETABLES;

EID: 85016128770     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8090529     Document Type: Review

References (127)

1. Surh, Y.J.Cancer chemoprevention with dietary phytochemicals.Nat.Rev.Cancer 2003, 3, 768-780.[CrossRef] [PubMed]
2. Russo, G.L.Ins and outs of dietary phytochemicals in cancer chemoprevention.Biochem.Pharmacol.2007, 74, 533-544.[CrossRef] [PubMed]
3. Kris-Etherton, P.; Lefevre, M.; Beecher, G.; Gross, M.; Keen, C.; Etherton, T.Bioactive compounds in nutrition and health-research methodologies for establishing biological function: The antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis.Annu.Rev.Nutr.2004, 24, 511-538.[CrossRef] [PubMed]
4. Kim, J.; Lee, H.J.; Lee, K.W.Naturally occurring phytochemicals for the prevention of Alzheimer’s disease.J.Neurochem.2010, 112, 1415-1430.[CrossRef] [PubMed]
5. Lee, K.W.; Bode, A.M.; Dong, Z.Molecular targets of phytochemicals for cancer prevention.Nat.Rev.Cancer 2011, 11, 211-218.[CrossRef] [PubMed]
6. Crowe, F.L.; Roddam, A.W.; Key, T.J.; Appleby, P.N.; Overvad, K.; Jakobsen, M.U.; Tjønneland, A.; Hansen, L.; Boeing, H.; Weikert, C.Fruit and vegetable intake and mortality from ischaemic heart disease: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study.Eur.Heart J.2011, 32, 1235-1243.[CrossRef] [PubMed]
7. Benavente-Garcia, O.; Castillo, J.Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity.J.Agric.Food.Chem.2008, 56, 6185-6205.[CrossRef] [PubMed]
8. Kanadaswami, C.; Lee, L.T.; Lee, P.P.; Hwang, J.J.; Ke, F.C.; Huang, Y.T.; Lee, M.T.The antitumor activities of flavonoids.In Vivo 2005, 19, 895-909.
9. Canivenc-Lavier, M.C.; Vernevaut, M.F.; Totis, M.; Siess, M.H.; Magdalou, J.; Suschetet, M.Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver.Toxicology 1996, 114, 19-27.[CrossRef]
10. Shih, H.; Pickwell, G.V.; Quattrochi, L.C.Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer.Arch.Biochem.2000, 373, 287-294.[CrossRef] [PubMed]
11. Murakami, A.; Ashida, H.; Terao, J.Multitargeted cancer prevention by quercetin.Cancer Lett.2008, 269, 315-325.[CrossRef] [PubMed]
12. Mendoza-Wilson, A.M.; Glossman-Mitnik, D.CHIH-DFT determination of the molecular structure, infrared and ultraviolet spectra of the flavonoid quercetin.J.Mol.Struc.Theochem.2004, 681, 71-76.[CrossRef]
13. Mendoza, E.; Burd, R.Quercetin as a systemic chemopreventative agent: Structural and functional mechanisms.Mini.Rev.Med.Chem.2011, 11, 1216-1221.[CrossRef] [PubMed]
14. Russo, G.L.; Russo, M.; Spagnuolo, C.; Tedesco, I.; Bilotto, S.; Iannitti, R.; Palumbo, R.Quercetin: A pleiotropic kinase inhibitor against cancer.In Advances in Nutrition and Cancer; Springer: Berlin/Heidelberg, Geramny, 2014; pp.185-205.
15. Sak, K.Site-specific anticancer effects of dietary flavonoid quercetin.Nutr.Cancer 2014, 66, 177-193.[CrossRef] [PubMed]
16. Brito, A.F.; Ribeiro, M.; Abrantes, A.M.; Pires, A.S.; Teixo, R.J.; Tralhao, G.J.; Botelho, M.F.Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics? Curr.Med.Chem.2015, 22, 3025-3039.[CrossRef] [PubMed]
17. Cook, N.; Samman, S.Flavonoids, chemistry, metabolism, cardioprotective effects, and dietary sources.J.Nutr.Biochem.1996, 7, 66-76.[CrossRef]
18. Materska, M.Quercetin and its derivatives: Chemical structure and bioactivity-A review.Pol.J.Food Nutr.Sci.2008, 58, 407-413.
19. Williams, C.A.; Grayer, R.J.Anthocyanins and other flavonoids.Nat.Prod.Rep.2004, 21, 539-573.[CrossRef] [PubMed]
20. Biesaga, M.; Pyrzynska, K.Analytical procedures for determination of quercetin and its glycosides in plant material.Crit.Rev.Chem.2009, 39, 95-107.[CrossRef]
21. Hollman, P.C.; Bijsman, M.N.; van Gameren, Y.; Cnossen, E.P.; de Vries, J.H.; Katan, M.B.The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man.Free Radic.Res.1999, 31, 569-573.[CrossRef] [PubMed]
22. Chen, X.; Mukwaya, E.; Wong, M.; Zhang, Y.A systematic review on biological activities of prenylated flavonoids.Pharm.Biol.2014, 52, 655-660.[CrossRef] [PubMed]
23. Inui, S.; Hosoya, T.; Shimamura, Y.; Masuda, S.; Ogawa, T.; Kobayashi, H.; Shirafuji, K.; Moli, R.T.; Kozone, I.; Shin-ya, K.; et al.Solophenols B-D and Solomonin: New Prenylated Polyphenols Isolated from Propolis Collected from The Solomon Islands and Their Antibacterial Activity.J.Agric.Food Chem.2012, 60, 11765-11770.[CrossRef] [PubMed]
24. Jia, S.; Ma, C.; Wang, J.Studies on flavonoid constituents isolated from the leaves of Glycyrrhiza uralensis Fisch.Acta Pharm.Sin.1989, 25, 758-762.
25. De Santiago, O.P.; Juliani, H.Isolation of quercetin 3,7,30,40-tetrasulphate from Flaveria bidentis L.Otto Kuntze.Experientia 1972, 28, 380-381.[CrossRef]
26. Dastagir, G.; Hussain, F.; Khan, A.A.Antibacterial activity of some selected plants of family Zygophyllaceae and Euphorbiaceae.J.Med.Plants Res.2012, 6, 5360-5368.
27. Boots, A.W.; Haenen, G.R.; Bast, A.Health effects of quercetin: From antioxidant to nutraceutical.Eur.J.Pharmacol.2008, 585, 325-337.[CrossRef] [PubMed]
28. Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J.Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships.J.Nutr.Biochem.2002, 13, 572-584.[CrossRef]
29. Dangles, O.; Dufoura, C.; Fargeixa, G.Inhibition of lipid peroxidation by quercetin and quercetin derivatives:Antioxidant and prooxidant effects.J.Chem.Soc.Perkin Trans.2000, 2, 1215-1222.[CrossRef]
30. Heijnen, C.G.; Haenen, G.R.; Minou Oostveen, R.; Stalpers, E.M.; Bast, A.Protection of flavonoids against lipid peroxidation: The structure activity relationship revisited.Free Radic.Res.2002, 36, 575-581.[CrossRef] [PubMed]
31. Murota, K.; Shimizu, S.; Miyamoto, S.; Izumi, T.; Obata, A.; Kikuchi, M.; Terao, J.Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: Comparison of isoflavonoids and flavonoids.J.Nutr.2002, 132, 1956-1961.[PubMed]
32. Terao, J.; Kawai, Y.; Murota, K.Vegetable flavonoids and cardiovascular disease.Asia Pac.J.Clin.Nutr.2008, 17, 291-293.[PubMed]
33. Moon, J.-H.; Nakata, R.; Oshima, S.; Inakuma, T.; Terao, J.Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women.Am.J.Physiol.Regul.Integr.Comp.Physiol.2000, 279, 461-467.
34. Shimoi, K.; Saka, N.; Nozawa, R.; Sato, M.; Amano, I.; Nakayama, T.; Kinae, N.Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation.Drug Metab.Dispos.2001, 29, 1521-1524.[PubMed]
35. De Boer, V.C.; Dihal, A.A.; van der Woude, H.; Arts, I.C.; Wolffram, S.; Alink, G.M.; Rietjens, I.M.C.M.; Keijer, J.; Hollman, P.C.H.Tissue distribution of quercetin in rats and pigs.J.Nutr.2005, 135, 1718-1725.[PubMed]
36. Kawai, Y.; Nishikawa, T.; Shiba, Y.; Saito, S.; Murota, K.; Shibata, N.; Kobayashi, M.; Kanayama, M.; Uchida, K.; Terao, J.Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries implication in the anti-atherosclerotic mechanism of dietary flavonoids.J.Biol.Chem.2008, 283, 9424-9434.[CrossRef] [PubMed]
37. Ahangarpour, A.; Eskandari, M.; Vaezlari, A.Effect of aqueous and hydroalcoholic extract of Beberis vulgaris on insulin secretion from islets of langerhans isolated from male mice.Armaghane Danesh 2012, 17, 289-298.
38. Ruckenstuhl, C.; Büttner, S.; Carmona-Gutierrez, D.; Eisenberg, T.; Kroemer, G.; Sigrist, S.J.; Fröhlich, K.U.; Madeo, F.The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer.PLoS ONE 2009, 4, 4592.[CrossRef]
39. Dajas, F.; Arredondo, F.; Echeverry, C.; Ferreira, M.; Morquio, A.; Rivera, F.Flavonoids and the brain:Evidences and putative mechanisms for a protective capacity.Curr.Neuropharmacol.2005, 3, 193-205.[CrossRef]
40. Ossola, B.; Kääriäinen, T.M.; Männistö, P.T.The multiple faces of quercetin in neuroprotection.Expert Opin.Drug Saf.2009, 8, 397-409.[CrossRef] [PubMed]
41. Greene, L.A.; Tischler, A.S.Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.Proc.Natl.Acad.Sci.USA 1976, 73, 2424-2428.[CrossRef] [PubMed]
42. Blasina, M.; Vaamonde, L.; Morquio, A.; Echeverry, C.; Arredondo, F.; Dajas, F.Differentiation induced by Achyrocline satureioides (Lam) infusion in PC12 cells.Phytother.Res.2009, 23, 1263-1269.[CrossRef] [PubMed]
43. Rydén, M.; Hempstead, B.; Ibáñez, C.F.Differential modulation of neuron survival during development by nerve growth factor binding to the p75 neurotrophin receptor.J.Biol.Chem.1997, 272, 16322-16328.[CrossRef] [PubMed]
44. Arredondo, F.; Echeverry, C.; Abin-Carriquiry, J.A.; Blasina, F.; Antúnez, K.; Jones, D.P.; Go, Y.M.; Liang, Y.L.; Dajas, F.After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult.Free Radic.Biol.Med.2010, 49, 738-747.[CrossRef] [PubMed]
45. Dajas, F.; Rivera, F.; Blasina, F.; Arredondo, F.; Echeverry, C.; Lafon, L.; Morquio, A.; Heizen, H.Cell culture protection and in vivo neuroprotective capacity of flavonoids.Neurotox.Res.2003, 5, 425-432.[CrossRef] [PubMed]
46. Kumar, A.; Sehgal, N.; Kumar, P.; Padi, S.; Naidu, P.Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats.Phytother.Res.2008, 22, 1563-1569.[CrossRef] [PubMed]
47. Patil, C.S.; Singh, V.P.; Satyanarayan, P.; Jain, N.K.; Singh, A.; Kulkarni, S.K.Protective effect of flavonoids against aging-and lipopolysaccharide-induced cognitive impairment in mice.Pharmacology 2003, 69, 59-67.[CrossRef] [PubMed]
48. Lu, J.; Zheng, Y.L.; Luo, L.; Wu, D.M.; Sun, D.X.; Feng, Y.J.Quercetin reverses D-galactose induced neurotoxicity in mouse brain.Behav.Brain Res.2006, 171, 251-260.[CrossRef] [PubMed]
49. Vissiennon, C.; Nieber, K.; Kelber, O.; Butterweck, V.Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin-Are they prodrugs? J.Nutr.Biochem.2012, 23, 733-740.[CrossRef] [PubMed]
50. Pu, F.; Mishima, K.; Irie, K.; Motohashi, K.; Tanaka, Y.; Orito, K.; Egawa, T.; Kitamura, Y.; Egashira, N.; Iwasaki, K.Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats.J.Pharmacol.Sci.2007, 104, 329-334.[CrossRef] [PubMed]
51. Schültke, E.; Kamencic, H.; Skihar, V.; Griebel, R.; Juurlink, B.Quercetin in an animal model of spinal cord compression injury: Correlation of treatment duration with recovery of motor function.Spinal Cord 2010, 48, 112-117.[CrossRef] [PubMed]
52. Youdim, K.A.; Shukitt-Hale, B.; Joseph, J.A.Flavonoids and the brain: Interactions at the blood-brain barrier and their physiological effects on the central nervous system.Free Radic.Biol.Med.2004, 37, 1683-1693.[CrossRef] [PubMed]
53. Boots, A.W.; Haenen, G.R.; den Hartog, G.J.; Bast, A.Oxidative damage shifts from lipid peroxidation to thiol arylation by catechol-containing antioxidants.Biochim.Biophys.Acta 2002, 1583, 279-284.[CrossRef]
54. Bindoli, A.; Valente, M.; Cavallini, L.Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activity.Pharmacol.Res.Commun.1985, 17, 831-839.[CrossRef]
55. Rendon-Mitchell, B.; Ochani, M.; Li, J.; Han, J.; Wang, H.; Yang, H.; Susarla, S.; Czura, C.; Mitchell, R.A.; Chen, G.IFN- induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.J.Immunol.2003, 170, 3890-3897.[CrossRef] [PubMed]
56. Andersson, U.; Wang, H.; Palmblad, K.; Aveberger, A.C.; Bloom, O.; Erlandsson-Harris, H.; Janson, A.; Kokkola, R.; Zhang, M.; Yang, H.; et al.High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.J.Exp.Med.2000, 192, 565-570.[CrossRef] [PubMed]
57. Degryse, B.; Bonaldi, T.; Scaffidi, P.; Müller, S.; Resnati, M.; Sanvito, F.; Arrigoni, G.; Bianchi, M.E.The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.J.Cell Biol.2001, 152, 1197-1206.[CrossRef] [PubMed]
58. Park, J.S.; Svetkauskaite, D.; He, Q.; Kim, J.Y.; Strassheim, D.; Ishizaka, A.; Abraham, E.Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.J.Biol.Chem.2004, 279, 7370-7377.[CrossRef] [PubMed]
59. Kokkola, R.; Andersson, A.; Mullins, G.; Östberg, T.; Treutiger, C.J.; Arnold, B.; Nawroth, P.; Andersson, U.; Harris, R.A.; Harris, H.E.RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.Scand.J.Immunol.2005, 61, 1-9.[CrossRef] [PubMed]
60. Luo, J.L.; Kamata, H.; Karin, M.IKK/NF-κB signaling: Balancing life and death-A new approach to cancer therapy.J.Clin.Investig.2005, 115, 2625-2632.[CrossRef] [PubMed]
61. Briot, A.; Deraison, C.; Lacroix, M.; Bonnart, C.; Robin, A.; Besson, C.; Dubus, P.; Hovnanian, A.Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.J.Exp.Med.2009, 206, 1135-1147.[CrossRef] [PubMed]
62. Wilson, S.R.; Thé, L.; Batia, L.M.; Beattie, K.; Katibah, G.E.; McClain, S.P.; Pellegrino, M.; Estandian, D.; Bautista, D.The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.Cell 2013, 155, 285-295.[CrossRef] [PubMed]
63. Zhong, J.; Sharma, J.; Raju, R.; Palapetta, S.M.; Prasad, T.K.; Huang, T.C.; Yoda, A.; Tyner, J.W.; Bodegom, D.V.; Weinstock, D.M.TSLP signaling pathway map: A platform for analysis of TSLP-mediated signaling.Database 2014, 2014.[CrossRef] [PubMed]
64. Arima, K.; Watanabe, N.; Hanabuchi, S.; Chang, M.; Sun, S.C.; Liu, Y.J.Distinct signal codes generate dendritic cell functional plasticity.Sci.Signal.2010, 3, 165.[CrossRef] [PubMed]
65. Bao, L.; Zhang, H.; Chan, L.S.The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis.JAK-STAT 2013, 2, 24137.[CrossRef] [PubMed]
66. Horr, B.; Borck, H.; Thurmond, R.; Grösch, S.; Diel, F.STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes.Int.Immunopharmacol.2006, 6, 1577-1585.[CrossRef] [PubMed]
67. Muthian, G.; Bright, J.J.Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.J.Clin.Immunol.2004, 24, 542-552.[CrossRef] [PubMed]
68. Liao, Y.R.; Lin, J.Y.Quercetin, but not its metabolite quercetin-3-glucuronide, exerts prophylactic immunostimulatory activity and therapeutic antiinflammatory effects on lipopolysaccharide-treated mouse peritoneal macrophages ex vivo.J.Agric.Food Chem.2014, 62, 2872-2880.[CrossRef] [PubMed]
69. Senggunprai, L.; Kukongviriyapan, V.; Prawan, A.; Kukongviriyapan, U.Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway.Phytother.Res.2014, 28, 841-848.[CrossRef] [PubMed]
70. Hämäläinen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E.Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages.Mediators Inflamm.2007, 2007, 45673.[PubMed]
71. Duo, J.; Ying, G.;Wang, G.W.; Zhang, L.Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation.Mol.Med.Rep.2012, 5, 1453-1456.[PubMed]
72. Kim, H.; Seo, E.M.; Sharma, A.R.; Ganbold, B.; Park, J.; Sharma, G.; Kang, Y.H.; Song, D.K.; Lee, S.S.; Nam, J.S.Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.Int.J.Oncol.2013, 43, 1319-1325.[PubMed]
73. Shan, B.E.;Wang, M.X.; Li, R.Q.Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/β-catenin signaling pathway.Cancer Investig.2009, 27, 604-612.[CrossRef] [PubMed]
74. Bhat, F.A.; Sharmila, G.; Balakrishnan, S.; Arunkumar, R.; Elumalai, P.; Suganya, S.; Raja, S.P.; Srinivasan, N.; Arunakaran, J.Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.J.Nutr.Biochem.2014, 25, 1132-1139.[CrossRef] [PubMed]
75. Maurya, A.K.; Vinayak, M.Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.Mol.Biol.Rep.2015, 42, 1419-1429.[CrossRef] [PubMed]
76. Sun, Z.J.; Chen, G.; Hu, X.; Zhang, W.; Liu, Y.; Zhu, L.X.; Zhou, Q.; Zhao, Y.F.Activation of PI3K/Akt/IKK-α/NF-βB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: Its inhibition by quercetin.Apoptosis 2010, 15, 850-863.[CrossRef] [PubMed]
77. Catanzaro, D.; Ragazzi, E.; Vianello, C.; Caparrotta, L.; Montopoli, M.Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell Lines.Nat.Prod.Commun.2015, 10, 1365-1368.[PubMed]
78. Priyadarsini, R.V.; Murugan, R.S.; Maitreyi, S.; Ramalingam, K.; Karunagaran, D.; Nagini, S.The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-αB inhibition.Eur.J.Pharmacol.2010, 649, 84-91.[CrossRef] [PubMed]
79. Yeh, S.L.; Yeh, C.L.; Chan, S.T.; Chuang, C.H.Plasma rich in quercetin metabolites induces G2/M arrest by upregulating PPAR- expression in human A549 lung cancer cells.Planta Med.2011, 77, 992-998.[CrossRef] [PubMed]
80. Kim, H.; Moon, J.Y.; Ahn, K.S.; Cho, S.K.Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells.Oxid.Med.Cell Longev.2013, 2013, 596496.[CrossRef] [PubMed]
81. Gulati, N.; Laudet, B.; Zohrabian, V.M.; Murali, R.; Jhanwar, M.U.The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway.Anticancer Res.2006, 26, 1177-1181.[PubMed]
82. Lee, D.H.; Lee, Y.J.Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α (HIF-1α) through inhibiting protein synthesis.J.Cell.Biochem.2008, 105, 546-553.[CrossRef] [PubMed]
83. Dihal, A.A.; van der Woude, H.; Hendriksen, P.J.; Charif, H.; Dekker, L.J.; IJsselstijn, L.; De Boer, V.C.J.; Alink, G.M.; Burgers, P.C.; Rietjens, I.M.C.M.Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis.Proteomics 2008, 8, 45-61.[CrossRef] [PubMed]
84. Braganhol, E.; Zamin, L.L.; Canedo, A.D.; Horn, F.; Tamajusuku, A.S.;Wink, M.R.; Salbego, C.; Battastini, A.M.Antiproliferative effect of quercetin in the human U138MG glioma cell line.Anticancer Drugs 2006, 17, 663-671.[CrossRef] [PubMed]
85. Lamson, D.W.; Brignall, M.S.Antioxidants and cancer, part 3: Quercetin.Altern.Med.Rev.J.Clin.Ther.2000, 5, 196-208.
86. Caltagirone, S.; Rossi, C.; Poggi, A.; Ranelletti, F.O.; Natali, P.G.; Brunetti, M.; Aiello, F.B.; Piantelli, M.Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.Int.J.Cancer 2000, 87, 595-600.[CrossRef]
87. Yang, C.S.; Landau, J.M.; Huang, M.T.; Newmark, H.L.Inhibition of carcinogenesis by dietary polyphenolic compounds.Annu.Rev.Nutr.2001, 21, 381-406.[CrossRef] [PubMed]
88. Deschner, E.E.; Ruperto, J.; Wong, G.; Newmark, H.L.Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia.Carcinogenesis 1991, 12, 1193-1196.[CrossRef] [PubMed]
89. Dihal, A.A.; de Boer, V.C.; van der Woude, H.; Tilburgs, C.; Bruijntjes, J.P.; Alink, G.M.; Rietjens, I.M.; Woutersen, R.A.; Stierum, R.H.Quercetin, but not its glycosidated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats.J.Nutr.2006, 136, 2862-2867.[PubMed]
90. Kato, R.; Nakadate, T.; Yamamoto, S.; Sugimura, T.Inhibition of 12-O-tetradecanoylphorbol-13- acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: Possible involvement of lipoxygenase inhibition.Carcinogenesis 1983, 4, 1301-1305.[CrossRef] [PubMed]
91. Khanduja, K.; Gandhi, R.; Pathania, V.; Syal, N.Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice.Food Chem.Toxicol.1999, 37, 313-318.[CrossRef]
92. Verma, A.K.; Johnson, J.A.; Gould, M.N.; Tanner, M.A.Inhibition of 7, 12-dimethylbenz (a) anthracene-and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.Cancer Res.1988, 48, 5754-5758.[PubMed]
93. Kumamoto, T.; Fujii, M.; Hou, D.X.Akt is a direct target for myricetin to inhibit cell transformation.Mol.Cell.Biochem.2009, 332, 33-41.[CrossRef] [PubMed]
94. Raman, M.; Chen, W.; Cobb, M.Differential regulation and properties of MAPKs.Oncogene 2007, 26, 3100-3112.[CrossRef] [PubMed]
95. Hanahan, D.; Weinberg, R.A.Hallmarks of cancer: The next generation.Cell 2011, 144, 646-674.[CrossRef] [PubMed]
96. Zamin, L.L.; Filippi-Chiela, E.C.; Dillenburg-Pilla, P.; Horn, F.; Salbego, C.; Lenz, G.Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells.Cancer Sci.2009, 100, 1655-1662.[CrossRef] [PubMed]
97. Cosan, D.T.; Soyocak, A.; Basaran, A.; Degirmenci, İ.; Gunes, H.V.; Sahin, F.M.Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines.Mol.Biol.Rep.2011, 38, 2463-2469.[CrossRef] [PubMed]
98. Russo, M.; Mupo, A.; Spagnuolo, C.; Russo, G.L.Exploring death receptor pathways as selective targets in cancer therapy.Biochem.Pharmacol.2010, 80, 674-682.[CrossRef] [PubMed]
99. Russo, M.; Palumbo, R.; Mupo, A.; Tosto, M.; Iacomino, G.; Scognamiglio, A.; Tedesco, I.; Galano, G.; Russo, G.L.Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα.Oncogene 2003, 22, 3330-3342.[CrossRef] [PubMed]
100. Russo, M.; Palumbo, R.; Tedesco, I.; Mazzarella, G.; Russo, P.; Iacomino, G.; Russo, G.L.Quercetin and anti-CD95 (Fas/Apo1) enhance apoptosis in HPB-ALL cell line.FEBS Lett.1999, 462, 322-328.[CrossRef]
101. Russo, M.; Nigro, P.; Rosiello, R.; D’Arienzo, R.; Russo, G.Quercetin enhances CD95-and TRAIL-induced apoptosis in leukemia cell lines.Leukemia 2007, 21, 1130-1133.[CrossRef] [PubMed]
102. Lee, K.W.; Kang, N.J.; Heo, Y.S.; Rogozin, E.A.; Pugliese, A.; Hwang, M.K.; Bowden, G.T.; Bode, A.M.; Lee, H.J.; Dong, Z.Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.Cancer Res.2008, 68, 946-955.[CrossRef] [PubMed]
103. Denison, M.S.; Pandini, A.; Nagy, S.R.; Baldwin, E.P.; Bonati, L.Ligand binding and activation of the Ah receptor.Chem.Biol.Interact.2002, 141, 3-24.[CrossRef]
104. Guengerich, F.P.; Shimada, T.Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.Chem.Res.Toxicol.1991, 4, 391-407.[CrossRef] [PubMed]
105. Moon, Y.J.; Wang, X.; Morris, M.E.Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism.Toxicol.in Vitro 2006, 20, 187-210.[CrossRef] [PubMed]
106. Ashida, H.; Fukuda, I.; Yamashita, T.; Kanazawa, K.Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin.FEBS Lett.2000, 476, 213-217.[CrossRef]
107. Fukuda, I.; Ashida, H.Suppressive effects of flavonoids on activation of the aryl hydrocarbon receptor induced by dioxins.In ACS Symposium Series; Oxford University Press: Cary, NC, USA, 2008; Volume 993, pp.369-374.
108. Van Der Woude, H.; Ter Veld, M.G.; Jacobs, N.; Van Der Saag, P.T.; Murk, A.J.; Rietjens, I.M.The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor.Mol.Nutr.Food Res.2005, 49, 763-771.[CrossRef] [PubMed]
109. Cappelletti, V.; Miodini, P.; Di Fronzo, G.; Daidone, M.G.Modulation of estrogen receptor-α isoforms by phytoestrogens in breast cancer cells.Int.J.Oncol.2006, 28, 1185-1191.[CrossRef] [PubMed]
110. Xing, N.; Chen, Y.; Mitchell, S.H.; Young, C.Y.Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.Carcinogenesis 2001, 22, 409-414.[CrossRef] [PubMed]
111. Yuan, H.; Gong, A.; Young, C.Y.Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.Carcinogenesis 2005, 26, 793-801.[CrossRef] [PubMed]
112. Duraj, J.; Zazrivcova, K.; Bodo, J.; Sulikova, M.; Sedlak, J.Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants.Neoplasma 2004, 52, 273-279.
113. Psahoulia, F.H.; Moumtzi, S.; Roberts, M.L.; Sasazuki, T.; Shirasawa, S.; Pintzas, A.Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells.Carcinogenesis 2007, 28, 1021-1031.[CrossRef] [PubMed]
114. Ishikawa, Y.; Kitamura, M.Anti-apoptotic effect of quercetin: Intervention in the JNK-and ERK-mediated apoptotic pathways.Kidney Int.2000, 58, 1078-1087.[CrossRef] [PubMed]
115. Marone, M.; D’Andrilli, G.; Das, N.; Ferlini, C.; Chatterjee, S.; Scambia, G.Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases.Exp.Cell Res.2001, 270, 1-12.[CrossRef] [PubMed]
116. Ferraresi, R.; Troiano, L.; Roat, E.; Lugli, E.; Nemes, E.; Nasi, M.; Pinti, M.; Fernandez, M.I.; Cooper, E.L.; Cossarizza, A.Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin.Free Radic.Res.2005, 39, 1249-1258.[CrossRef] [PubMed]
117. Robaszkiewicz, A.; Balcerczyk, A.; Bartosz, G.Antioxidative and prooxidative effects of quercetin on A549 cells.Cell Biol.Int.2007, 31, 1245-1250.[CrossRef] [PubMed]
118. Zebisch, A.; Czernilofsky, A.P.; Keri, G.; Smigelskaite, J.; Sill, H.; Troppmair, J.Signaling through RAS-RAF-MEK-ERK: From basics to bedside.Curr.Med.Chem.2007, 14, 601-623.[CrossRef] [PubMed]
119. Nguyen, T.; Tran, E.; Nguyen, T.; Do, P.; Huynh, T.; Huynh, H.The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells.Carcinogenesis 2004, 25, 647-659.[CrossRef] [PubMed]
120. Cho, S.Y.; Park, S.J.; Kwon, M.J.; Jeong, T.S.; Bok, S.H.; Choi,W.Y.; Jeong,W.I.; Ryu, S.Y.; Do, S.H.; Lee, C.S.Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-αB pathway in lipopolysaccharide-stimulated macrophage.Mol.Cell.Biochem.2003, 243, 153-160.[CrossRef] [PubMed]
121. Ross, J.A.; Kasum, C.M.Dietary flavonoids: Bioavailability, metabolic effects, and safety.Annu.Rev.Nutr.2002, 22, 19-34.[CrossRef] [PubMed]
122. Neuhouser, M.L.Review: Dietary flavonoids and cancer risk: Evidence from human population studies.Nutr.Cancer 2004, 50, 1-7.[CrossRef] [PubMed]
123. Hirvonen, T.; Virtamo, J.; Korhonen, P.; Albanes, D.; Pietinen, P.Flavonol and flavone intake and the risk of cancer in male smokers (Finland).Cancer Causes Control 2001, 12, 797-802.[CrossRef]
124. Hertog, M.G.; Hollman, P.C.; Katan, M.B.; Kromhout, D.Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.Nutr.Cancer 1993, 20, 21-29.[CrossRef] [PubMed]
125. Stefani, E.D.; Boffetta, P.; Deneo-Pellegrini, H.; Mendilaharsu, M.; Carzoglio, J.C.; Ronco, A.; Olivera, L.Dietary antioxidants and lung cancer risk: A case-control study in Uruguay.Nutr.Cancer 1999, 34, 100-110.[CrossRef] [PubMed]
126. Nöthlings, U.; Murphy, S.P.;Wilkens, L.R.; Henderson, B.E.; Kolonel, L.N.Flavonols and pancreatic cancer risk the multiethnic cohort study.Am.J.Epidemiol.2007, 166, 924-931.[CrossRef] [PubMed]
127. Gates, M.A.; Tworoger, S.S.; Hecht, J.L.; De Vivo, I.; Rosner, B.; Hankinson, S.E.A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.Int.J.Cancer 2007, 121, 2225-2232.[CrossRef] [PubMed]